Die Ludwig-Maximilians-Universität München ist eine Universität in München. Sie wurde 1472 in Ingolstadt gegründet, im Jahre 1800 nach Landshut und 1826 schließlich nach München verlegt. Sie ist benannt nach ihrem Gründer Herzog Ludwig IX. sowie dem bayerischen König Maximilian I. Joseph, der sie nach Landshut holte.

During the past decade, University of Munich conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 9 clinical trials were completed, i.e. on average, 19.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 8 clinical trials were completed. i.e. 38.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Munich" #1 sponsor was "Ludwig-Maximilians - University of Munich" with 16 trials, followed by "IntraBio Inc" with 4 trials sponsored, "PD Dr. med. Volker Heinemann" with 3 trials sponsored, "University Hospital Tuebingen" with 3 trials sponsored and "AO Clinical Investigation and Publishing Documentation" with 3 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Munich" #1 collaborator was "Ludwig-Maximilians - University of Munich" with 5 trials as a collaborator, "Roche Pharma AG" with 3 trials as a collaborator, "AOCMF" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Auckland District Health Board" with 1 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "University of Munich" are "Atherosclerosis" (2 trials), "Coronary Artery Disease" (2 trials), "Depression" (2 trials), "Dermatitis, Atopic" (2 trials) and "Intracerebral Hemorrhage" (2 trials). Many other conditions were trialed in "University of Munich" in a lesser frequency.

Most popular intervention types in "University of Munich" are "Drug" (36 trials), "Device" (11 trials), "Other" (9 trials), "Procedure" (8 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "5-FU" (3 trials), "IB1001" (3 trials), "Edasalonexent" (2 trials) and "Folinic Acid" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Munich" are 70 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Munich". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in University of Munich, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Munich, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 19 trials that are defined as “Not Applicable".